WO2004060279A3 - Use of silver sulfadiazine for viral aliments, and preparations and combinations therefor - Google Patents

Use of silver sulfadiazine for viral aliments, and preparations and combinations therefor Download PDF

Info

Publication number
WO2004060279A3
WO2004060279A3 PCT/US2003/038880 US0338880W WO2004060279A3 WO 2004060279 A3 WO2004060279 A3 WO 2004060279A3 US 0338880 W US0338880 W US 0338880W WO 2004060279 A3 WO2004060279 A3 WO 2004060279A3
Authority
WO
WIPO (PCT)
Prior art keywords
silver sulfadiazine
viral
ailment
aliments
disclosed
Prior art date
Application number
PCT/US2003/038880
Other languages
French (fr)
Other versions
WO2004060279A2 (en
Inventor
Thomas D Stone
Mary Jo Brown
Original Assignee
Thomas D Stone
Mary Jo Brown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas D Stone, Mary Jo Brown filed Critical Thomas D Stone
Priority to AU2003297704A priority Critical patent/AU2003297704A1/en
Publication of WO2004060279A2 publication Critical patent/WO2004060279A2/en
Publication of WO2004060279A3 publication Critical patent/WO2004060279A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Novel and inventive uses of Silver Sulfadiazine are disclosed, as well as associated preparations and combinations. These include: a method of treating a viral ailment, comprising the step of: applying Silver Sulfadiazine proximate a site upon a person’s skin where said viral ailment is manifest; using Silver Sulfadiazine to treat a viral ailment; and distributing Silver Sulfadiazine to treat a viral ailment. Also disclosed is a medically-prescriptive combination for treating a viral ailment, comprising: Silver Sulfadiazine, and instructions to use said Silver Sulfadiazine to treat a viral ailment. Further disclosed is Silver Sulfadiazine, prepared at various strengths of less than 1%, as well as preparing Silver Sulfadiazine at various strengths of less than 1%. These strengths may be suitable for the viral ailments disclosed, although they are not strong enough for bacterial and fungal aliments for which Silver Sulfadiazine is ordinarily used.
PCT/US2003/038880 2003-01-02 2003-12-08 Use of silver sulfadiazine for viral aliments, and preparations and combinations therefor WO2004060279A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003297704A AU2003297704A1 (en) 2003-01-02 2003-12-08 Use of silver sulfadiazine for viral aliments, and preparations and combinations therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43750003P 2003-01-02 2003-01-02
US60/437,500 2003-01-02

Publications (2)

Publication Number Publication Date
WO2004060279A2 WO2004060279A2 (en) 2004-07-22
WO2004060279A3 true WO2004060279A3 (en) 2005-03-17

Family

ID=32713191

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/038880 WO2004060279A2 (en) 2003-01-02 2003-12-08 Use of silver sulfadiazine for viral aliments, and preparations and combinations therefor

Country Status (2)

Country Link
AU (1) AU2003297704A1 (en)
WO (1) WO2004060279A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287204A2 (en) * 1987-02-25 1988-10-19 The Trustees of Columbia University in the City of New York Silver sulfadiazine useful for inhibiting the transmission of the aids virus
EP0355009A1 (en) * 1988-08-18 1990-02-21 Konrad Minninger Silver sulfadiazine containing pharmaceutical product for the local external therapy
US5679337A (en) * 1991-06-14 1997-10-21 Professional Pharmaceutical, Inc. Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287204A2 (en) * 1987-02-25 1988-10-19 The Trustees of Columbia University in the City of New York Silver sulfadiazine useful for inhibiting the transmission of the aids virus
EP0355009A1 (en) * 1988-08-18 1990-02-21 Konrad Minninger Silver sulfadiazine containing pharmaceutical product for the local external therapy
US5679337A (en) * 1991-06-14 1997-10-21 Professional Pharmaceutical, Inc. Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TOKUMARU, T ET AL.: "Antiviral Activities of Silver Sulfadiazine in Ocular Infection", RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, vol. 8, no. 1, May 1974 (1974-05-01), pages 151 - 158, XP008042970 *

Also Published As

Publication number Publication date
AU2003297704A1 (en) 2004-07-29
AU2003297704A8 (en) 2004-07-29
WO2004060279A2 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
WO2003032994A3 (en) Novel tri-substituted pyrimidines, method for production and use thereof as medicament
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
WO2005096990A3 (en) Novel modification of medical prostheses
WO2003092580A3 (en) Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
WO2004108764A3 (en) Connective tissue growth factor antibodies
WO2004080380A3 (en) Use of catechuic polyphenols for preparing compositions for stimulating a skin's natural pigmentation
WO2004093722A3 (en) Topical treatment of dermatological disorders associated with reactive or dilated blood vessels
WO2005051288A3 (en) Compositions for achieving benefits in skin using key cellular metabolic intermediates
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
WO2004004653A3 (en) Methods for treating psychosis associated with interferon-alpha therapy
WO2003045324A3 (en) 14-methyl-epothilones
HK1063601A1 (en) Compositions and methods for treating hyperimmune response in the eye
WO2002051379A3 (en) Thixotropic nasal spray
WO2002087503A3 (en) Compositions and methods for treating colorectal polyps and cancer
CA2505500A1 (en) Method of stimulating hair growth using benzopyrans
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
WO2005058280A3 (en) Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
WO2004060279A3 (en) Use of silver sulfadiazine for viral aliments, and preparations and combinations therefor
WO2003092669A3 (en) Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP